Increased Monocyte/Lymphocyte Ratio as Risk Marker for Cardiovascular Events and Infectious Disease Hospitalization in Dialysis Patients

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:150745267" > Increased Monocyte/...

1 av 1
Föregående post
Nästa post
Till träfflistan

Muto, R (författare)

Increased Monocyte/Lymphocyte Ratio as Risk Marker for Cardiovascular Events and Infectious Disease Hospitalization in Dialysis Patients

Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

2021-11-23
S. Karger AG,2022

Nummerbeteckningar

LIBRIS-ID:oai:prod.swepub.kib.ki.se:150745267
http://kipublications.ki.se/Default.aspx?queryparsed=id:150745267URI
https://doi.org/10.1159/000519289DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Introduction: In dialysis patients, cardiovascular disease (CVD) and infectious disease contribute to poor clinical outcomes. We investigated if a higher monocyte/lymphocyte ratio (MLR) is associated with an increased risk of CVD events and infectious disease hospitalizations in incident dialysis patients. Methods: In an ongoing observational prospective cohort study, 132 Japanese dialysis patients (age 58.7 ± 11.7 years; 70% men) starting dialysis therapy were enrolled and followed up for a median of 48.7 months. Laboratory biomarkers, including white blood cell count and its differential count, were determined at baseline. Event-free time and relative risks (RRs) were calculated using the Kaplan-Meier curves and Cox models, respectively. Results: When divided into 2 groups according to median MLR (0.35 [range, 0.27–0.46]), the periods without CVD events were significantly shorter in the high MLR group than in the low MLR group (log-rank test = 5.60, p = 0.018). The RR of CVD events, after adjusting for age, sex, and diabetes, was 2.43 (1.22–4.84) in the high MLR group compared to the low MLR group. The periods without infections requiring hospitalization were also shorter (log-rank test = 4.16, p = 0.041). The RR of infections requiring hospitalization was 1.98 (1.02–3.83) after the same adjustments. The number of CVD events was higher in the high MLR group (18.6 events per 100 person-years at risk [pyr]) than the low MLR group (11.1 events per 100 pyr). The duration of infectious disease hospitalization was longer in the high MLR group (6.3 days per pyr) than in the low MLR group (2.8 days per pyr). Conclusion: A higher MLR is associated with increased risks of both CVD events and infectious disease hospitalization in dialysis patients.

Biuppslag (personer, institutioner, konferenser, titlar ...)

Kato, S (författare)
Lindholm, BKarolinska Institutet (författare)
Qureshi, ARKarolinska Institutet (författare)
Ishimoto, T (författare)
Kosugi, T (författare)
Maruyama, S (författare)
Karolinska Institutet (creator_code:org_t)

Sammanhörande titlar

Ingår i:Blood purification: S. Karger AG51:9, s. 747-7551421-97350253-5068

Internetlänk

Hitta via bibliotek

Blood purification (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Muto, R; Kato, S; Lindholm, B; Qureshi, AR; Ishimoto, T; Kosugi, T; visa fler...; Maruyama, S; visa färre...

Artiklar i publikationen: Blood purificati ...

Av lärosätet: Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se